(NYSE: CHE) Chemed's forecast annual revenue growth rate of 8.08% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 9.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,474.34%.
Chemed's revenue in 2026 is $2,530,634,000.On average, 5 Wall Street analysts forecast CHE's revenue for 2026 to be $38,739,073,325, with the lowest CHE revenue forecast at $37,039,369,925, and the highest CHE revenue forecast at $40,764,553,210.
In 2027, CHE is forecast to generate $40,396,284,140 in revenue, with the lowest revenue forecast at $39,121,506,590 and the highest revenue forecast at $42,067,659,150.